These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 9758595)
21. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease. Wittström E; Nordling M; Andréasson S Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745 [TBL] [Abstract][Full Text] [Related]
22. Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas. Tse JY; Wong JH; Lo KW; Poon WS; Huang DP; Ng HK Am J Clin Pathol; 1997 Apr; 107(4):459-66. PubMed ID: 9124215 [TBL] [Abstract][Full Text] [Related]
23. A variety of phenotype with R161Q germline mutation of the von Hippel-Lindau tumor suppressor gene in Japanese kindred. Iida K; Okimura Y; Takahashi K; Inomata S; Iguchi G; Kaji H; Chihara K Int J Mol Med; 2004 Mar; 13(3):401-4. PubMed ID: 14767570 [TBL] [Abstract][Full Text] [Related]
24. [Von Hippel-Lindau disease]. Shuin T; Ashida S; Yao M; Kanno H Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322 [TBL] [Abstract][Full Text] [Related]
26. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]. Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
28. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Decker HJ; Weidt EJ; Brieger J Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583 [TBL] [Abstract][Full Text] [Related]
29. Should endolymphatic sac tumors be considered part of the von Hippel-Lindau complex? Pathology case report. Tibbs RE; Bowles AP; Raila FA; Fratkin JD; Hutchins JB Neurosurgery; 1997 Apr; 40(4):848-55; discussion 855. PubMed ID: 9092862 [TBL] [Abstract][Full Text] [Related]
30. Molecular genetic analysis and mutation screening of the VHL gene in a Japanese family with von Hippel-Lindau disease. Wu Y; Nishio H; Lee MJ; Ayaki H; Hayashi A; Ooba T; Ogawa T; Sumino K Kobe J Med Sci; 2000 Aug; 46(4):147-53. PubMed ID: 11354926 [TBL] [Abstract][Full Text] [Related]
31. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531 [TBL] [Abstract][Full Text] [Related]
32. Genetic study of a large Chinese kindred with von Hippel-Lindau disease. Huang YR; Zhang J; Wang JD; Fan XD Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448 [TBL] [Abstract][Full Text] [Related]
33. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Friedrich CA Hum Mol Genet; 2001 Apr; 10(7):763-7. PubMed ID: 11257110 [TBL] [Abstract][Full Text] [Related]
34. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531 [TBL] [Abstract][Full Text] [Related]
36. Variable penetrance of familial pheochromocytoma associated with the von Hipple Lindau gene mutation, S68W. Mutations in brief no. 150. Online. Martin R; Hockey A; Walpole I; Goldblatt J Hum Mutat; 1998; 12(1):71. PubMed ID: 10627136 [TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097 [TBL] [Abstract][Full Text] [Related]
38. [Genetic analysis of a family with Von Hippel-Lindau syndrome]. Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968 [TBL] [Abstract][Full Text] [Related]
39. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849 [TBL] [Abstract][Full Text] [Related]
40. Von Hippel-Lindau disease: the role of gene analysis in affected families. Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]